ES8104271A1 - Procedimiento para la preparacion de 5-(2-((3-(1,3-benzodio-sol-5-il)-1-metilpropil)amino)-1-hidroxietil-2-metoxibenza- mida y de sus sales e isomeros opticos farmaceuticamente aceptables - Google Patents

Procedimiento para la preparacion de 5-(2-((3-(1,3-benzodio-sol-5-il)-1-metilpropil)amino)-1-hidroxietil-2-metoxibenza- mida y de sus sales e isomeros opticos farmaceuticamente aceptables

Info

Publication number
ES8104271A1
ES8104271A1 ES490815A ES490815A ES8104271A1 ES 8104271 A1 ES8104271 A1 ES 8104271A1 ES 490815 A ES490815 A ES 490815A ES 490815 A ES490815 A ES 490815A ES 8104271 A1 ES8104271 A1 ES 8104271A1
Authority
ES
Spain
Prior art keywords
compound
antihypertensive agent
formula
image
novel antihypertensive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES490815A
Other languages
English (en)
Other versions
ES490815A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richardson Vicks Inc
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of ES490815A0 publication Critical patent/ES490815A0/es
Publication of ES8104271A1 publication Critical patent/ES8104271A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE 5-(2-((3-(1,3-BENZODIOXOL-5-IL)-1-METIL-PROPIL)AMINO)-1-HIDROXIETIL)-2- METOXIBENZAMIDA, DE FORMULA: *FORMULA* SUS SALES E ISOMEROS OPTICOS, DE APLICACION EN EL TRATAMIENTO DE LA HIPERTENSION. CONSISTE EN TRATAR METIL-5-ACETIL-2-METOXIBENZOATO, O 5-ACETIL-2-METOXIBENZAMIDA, CON UN AGENTE BROMADOR EN UN DISOLVENTE INERTE A 25GC, A REFLUJO, AÑADIENDO LA BROMOCETONA ASI OBTENIDA A UNA SOLUCION AGITADA DE 3-(1,3-BENZODIOXOL-5-1)1-METILPROPILAMINA Y UNA TRI (INFERIOR) ALQUILAMINA, DE 0 A 50GC Y DURANTE LAS VEINTICUATRO HORAS, REDUCIENDO FINALMENTE EL PRODUCTO OBTENIDO.
ES490815A 1979-05-04 1980-04-23 Procedimiento para la preparacion de 5-(2-((3-(1,3-benzodio-sol-5-il)-1-metilpropil)amino)-1-hidroxietil-2-metoxibenza- mida y de sus sales e isomeros opticos farmaceuticamente aceptables Expired ES8104271A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,256 US4221808A (en) 1979-05-04 1979-05-04 Novel antihypertensive agent

Publications (2)

Publication Number Publication Date
ES490815A0 ES490815A0 (es) 1981-04-16
ES8104271A1 true ES8104271A1 (es) 1981-04-16

Family

ID=21887574

Family Applications (1)

Application Number Title Priority Date Filing Date
ES490815A Expired ES8104271A1 (es) 1979-05-04 1980-04-23 Procedimiento para la preparacion de 5-(2-((3-(1,3-benzodio-sol-5-il)-1-metilpropil)amino)-1-hidroxietil-2-metoxibenza- mida y de sus sales e isomeros opticos farmaceuticamente aceptables

Country Status (21)

Country Link
US (1) US4221808A (es)
JP (1) JPS55147273A (es)
AT (1) AT369364B (es)
AU (1) AU529943B2 (es)
BE (1) BE883088A (es)
CA (1) CA1139772A (es)
CH (1) CH644856A5 (es)
DE (1) DE3014775A1 (es)
DK (1) DK153792C (es)
ES (1) ES8104271A1 (es)
FR (1) FR2455597A1 (es)
GB (1) GB2048874B (es)
IE (1) IE49565B1 (es)
IL (1) IL59729A (es)
IT (1) IT1145434B (es)
NL (1) NL8002209A (es)
NO (1) NO153571C (es)
NZ (1) NZ193235A (es)
PH (1) PH15564A (es)
SE (1) SE447825B (es)
ZA (1) ZA801723B (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1260521A (en) * 1969-02-06 1972-01-19 Allen & Hanburys Ltd Phenethanolamine ethers
GB1468673A (en) * 1973-05-07 1977-03-30 Allen & Hanburys Ltd Substituted benzamides
US3883560A (en) * 1973-07-05 1975-05-13 Colgate Palmolive Co Salicylamidophenethanolamines

Also Published As

Publication number Publication date
NZ193235A (en) 1982-09-07
IE800573L (en) 1980-11-04
NO801299L (no) 1980-11-05
FR2455597B1 (es) 1983-04-29
FR2455597A1 (fr) 1980-11-28
IL59729A0 (en) 1980-06-30
SE447825B (sv) 1986-12-15
ES490815A0 (es) 1981-04-16
JPS55147273A (en) 1980-11-17
CH644856A5 (de) 1984-08-31
PH15564A (en) 1983-02-11
NO153571C (no) 1986-04-16
DE3014775A1 (de) 1980-11-13
DK193480A (da) 1980-11-05
DK153792C (da) 1989-01-23
SE8003246L (sv) 1980-11-05
AU5707880A (en) 1980-11-06
DE3014775C2 (es) 1989-06-15
ATA232680A (de) 1982-05-15
IT8048324A0 (it) 1980-04-02
IL59729A (en) 1984-01-31
GB2048874B (en) 1982-12-01
GB2048874A (en) 1980-12-17
NL8002209A (nl) 1980-11-06
DK153792B (da) 1988-09-05
CA1139772A (en) 1983-01-18
AU529943B2 (en) 1983-06-23
US4221808A (en) 1980-09-09
ZA801723B (en) 1981-03-25
BE883088A (fr) 1980-09-01
IT1145434B (it) 1986-11-05
IE49565B1 (en) 1985-10-30
JPH0138790B2 (es) 1989-08-16
AT369364B (de) 1982-12-27
NO153571B (no) 1986-01-06

Similar Documents

Publication Publication Date Title
CA2113229A1 (en) Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
SE7614258L (sv) Forfarande for framstellning av kinazoloderivat
ES2055860T3 (es) Derivados 2-aminopirimidinona.
MY110627A (en) [(benzodioxan, benzofuran or benzopyran) alkylamino] alkyl substituted guandines
DE3271269D1 (en) Benzimidazole derivatives, process for the preparation thereof and pharmaceutical composition containing the same
PH25504A (en) Novel substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides pharmaceutical composition containing said compound, method of use thereof
HUP9902130A2 (hu) 5-Metil-izoxazol-4-karbonsav-(4-trifluor-metil)-anilidet és N-(4-trifluor-metil-fenil)-2-ciano-3-hidroxi-krotonsav-amidot tartalmazó kombinált készítmény
DK0453042T3 (da) Hidtil ukendte 2 9-disubstituerede 4H-pyhrido[1 2-a]pyridin-4-oner
SE0102055D0 (sv) New Compounds
ES2124256T3 (es) Arilmorfolina, preparacion y uso.
NO176018C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive S-enantiomerer av substituerte 2-aminotetraliner
ES2104938T3 (es) Metodo de inhibir la fibrosis.
ES8104271A1 (es) Procedimiento para la preparacion de 5-(2-((3-(1,3-benzodio-sol-5-il)-1-metilpropil)amino)-1-hidroxietil-2-metoxibenza- mida y de sus sales e isomeros opticos farmaceuticamente aceptables
ID21755A (id) Antijamur azol yang mengandung ester asam amino
JPS6466116A (en) Antiemetic containing specific substituted phenylalkylamino and amino acid derivatives and compound selected from other serotonin drying drugs
ES8203837A1 (es) Un procedimiento para la preparacion de derivados de propa- nolamina
SE9202218D0 (sv) Pharmacologically active alfa-(tertiary-aminomethyl)-benzenemethanol derivatives, pharmaceutical composition containing them, therapeutical use thereof and processes for their preparation
ES8202554A1 (es) Procedimiento para la preparacion de 2-fenilamino-imidazoli-nas-(2)sustituidas
IL62310A0 (en) 1-(acylamino-aryloxy)-3-alkynylamino-propan-2-ols,their preparation and pharmaceutical compositions containing them
ES2061579T3 (es) Compuestos cefem y procedimientos para su preparacion.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020304